Loading...
The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survival
Glioblastoma (GBM) is resistant to multimodality therapeutic approaches. A high burden of tumor-specific mutant peptides (neoantigens) correlates with better survival and response to immunotherapies in selected solid tumors but how neoantigens impact clinical outcome in GBM remains unclear. Here, we...
Saved in:
Published in: | Commun Biol |
---|---|
Main Authors: | , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Nature Publishing Group UK
2019
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6478916/ https://ncbi.nlm.nih.gov/pubmed/31044160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-019-0369-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|